Jan 28 (Reuters) – Countries are scrambling to buy the antiviral pills developed by Merck and Pfizer for adult COVID-19 patients.
The European Medicines Agency on Jan. 27 gave the green light to use Pfizer’s antiviral COVID-19 pill for treating adults at risk of severe illness. The regulator expects to give a final ruling on Merck’s molnupiravir by the end of February.
On Friday, India’s Dr.Reddy’s Labs said it had started commercial production of a generic version of Merck’s treatment. Egypt, which approved Merck’s COVID pill on Jan. 25, said the drug will be produced locally.
(Reporting by Ina Kreutz, Agnieszka Gosciak and Federica Urso; Editing by Milla Nissi and Philippa Fletcher)
The director of the UN office for the high commissioner for human rights in New…
G7 nations called for urgent actions to help civilians trapped in Gaza, facing bombardments, displacement…
As Houstonians head to the polls to elect a new mayor and representatives to city…
The US Secretary of State, Antony Blinken, has emphasized the need for the Palestinian Authority…
Delegates from 28 countries, including the US and China met this Wednesday in the first…
Chinese President Xi Jinping said China is willing to cooperate with the US and to…